DOREEN KARAN: Open Payments
NPI 1598120693 · BALA CYNWYD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 8 payments from 7 companies in 2025. Trend: 2023 $313 · 2024 $989 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $142 |
| AKEBIA THERAPEUTICS INC | 1 | $125 |
| Astellas Pharma US Inc | 1 | $120 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| Novo Nordisk Inc | 1 | $62 |
Products named: DRIZALMA SPRINKLE, Vafseo, AREXVY, Veozah, Natroba, JARDIANCE, NUCALA, Ozempic.
Industry payments across PA — which companies pay providers there.
